Resonant Biotechnologies Sues 14 Pharmaceutical Companies

  • August 10, 2011

Resonant Biotechnologies filed suit against Athena Neurosciences, Bristol-Myers Squibb, Caliper Life Sciences, Cambridge Research, Elan, Highres Biosolutions, Marizyme, Novascreen, Oceanix, PLC, SRU, X-Body, X-Chem, and Xenogen over a patent related to methods of analyzing molecular species by employing an optical sensor device.  8/5, District of New Jersey, 3:2011cv04570.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×